citrate antigen retrieval buffer (Servicebio Inc)
86
Structured Review
Servicebio Inc
citrate antigen retrieval buffer
Citrate Antigen Retrieval Buffer, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antigen+retrieval+citrate+buffer/antigen+retrieval/pmc13050104-93-11-16
Average 86 stars, based on 1 article reviews
Citrate Antigen Retrieval Buffer, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antigen+retrieval+citrate+buffer/antigen+retrieval/pmc13050104-93-11-16
Average 86 stars, based on 1 article reviews
citrate antigen retrieval buffer - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Incubation:Article Title: Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson's disease and neuronal damage through inhibition of microglia. Article Snippet: After adding the TH primary antibody and then the secondary antibody, FITC-TSA (Servicebio) was added, and the sections were incubated in the dark for 10 minutes. .. After Staining:Article Title: Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson's disease and neuronal damage through inhibition of microglia. Article Snippet: After adding the TH primary antibody and then the secondary antibody, FITC-TSA (Servicebio) was added, and the sections were incubated in the dark for 10 minutes. .. After Article Title: Discovery of a potent Gilteritinib-based FLT3-PROTAC degrader for the treatment of Acute myeloid leukemia. Article Snippet: Fms-like tyrosine receptor kinase 3 (FLT3) proteolysis targeting chimeras (PROTACs) emerge as a promising approach to overcome the limitations of FLT3 inhibitors, while the development of orally bioavailable FLT3PROTACs faces great challenges.. Here, we report the rational design and evaluation of a series of Gilteritinibbased FLT3-PROTACs.. Among them, B3-2 exhibited the strongest antiproliferative activity against FLT3-ITD mutant AML cells, and significantly induced FLT3-ITD protein degradation. Immunohistochemistry:Article Title: Discovery of a potent Gilteritinib-based FLT3-PROTAC degrader for the treatment of Acute myeloid leukemia. Article Snippet: Fms-like tyrosine receptor kinase 3 (FLT3) proteolysis targeting chimeras (PROTACs) emerge as a promising approach to overcome the limitations of FLT3 inhibitors, while the development of orally bioavailable FLT3PROTACs faces great challenges.. Here, we report the rational design and evaluation of a series of Gilteritinibbased FLT3-PROTACs.. Among them, B3-2 exhibited the strongest antiproliferative activity against FLT3-ITD mutant AML cells, and significantly induced FLT3-ITD protein degradation. Multiplex Assay:Article Title: Co-Delivery of aPD-L1 and CD73 Inhibitor Using Calcium Phosphate Nanoparticles for Enhanced Melanoma Immunotherapy with Reduced Toxicity. Article Snippet: .. Multiplex Immunohistochemical (Multi-IHC) Assay: Tumor tissue slides (3–5 μm) were dewaxed and rehydrated using a gradient alcohol series, followed by Immunohistochemical staining:Article Title: Co-Delivery of aPD-L1 and CD73 Inhibitor Using Calcium Phosphate Nanoparticles for Enhanced Melanoma Immunotherapy with Reduced Toxicity. Article Snippet: .. Multiplex Immunohistochemical (Multi-IHC) Assay: Tumor tissue slides (3–5 μm) were dewaxed and rehydrated using a gradient alcohol series, followed by |